Paychex, Inc. · PAYX · FY2026 Q4 · Calendar Q2 2026
Paychex Closes FY26 With 17% Revenue Growth, Sets 5–6% FY27 Outlook
Paychex closed fiscal 2026 with broad-based strength: full-year revenue grew 17% to $6.5B, Q4 EPS of $1.32 narrowly beat the $1.31 consensus, and margins expanded over 70 basis points. The Paycor acquisition is delivering synergies ahead of plan with over $100M in cost savings realized and cross-sell momentum across ASO, PO, and retirement. The Wise AI platform has scaled to roughly 600 features and represents both a productivity lever and a future monetization path. Management's FY27 guidance — 5–6% revenue growth, ~44% adjusted operating margin, and 7–9% EPS growth — signals a deliberate step-down from FY26's acquisition-boosted growth but reflects confidence in durable organic expansion. The market initially sold off on the print (-1.68% abnormal) but the stock subsequently drifted 14.9% higher to $122.13, well above the analyst consensus target of $108.80, suggesting investors…
Company context
Snapshot as of publicationFounded in 1971 and headquartered in Rochester, New York, Paychex, Inc. delivers comprehensive human capital management (HCM) solutions. The company primarily serves small to medium-sized enterprises (SMEs) across the United States, Europe, and India, addressing their needs in human resources, payroll administration, employee benefits, and insurance. Its diverse service portfolio includes: Payroll Management: Encompassing core payroll processing, payroll tax administration, employee payment facilitation, and ensuring compliance with regulations like new-hire reporting and garnishment processing. Human Resources Solutions: Providing support for employer compliance, HR and employee benefits administration, risk management outsourcing, and even the availability of professionally trained on-site HR representatives.…
Earnings scorecard
Reported versus consensusEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 30, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| UBS | Neutral | Neutral | Maintain | Jul 22, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jun 30, 2026 |
| JP Morgan | Underweight | Underweight | Maintain | Jun 25, 2026 |
| Stifel | Hold | Hold | Maintain | Jun 17, 2026 |
| Citigroup | Buy | Neutral | Upgrade | Jun 15, 2026 |
| TD Cowen | Hold | Hold | Maintain | Jun 8, 2026 |
| Wells Fargo | Underweight | Underweight | Maintain | Mar 26, 2026 |
| Baird | Neutral | Neutral | Maintain | Mar 26, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Mar 19, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Mar 13, 2026 |
| Jefferies | Hold | Hold | Maintain | Dec 8, 2025 |
| Barclays | Equal Weight | Equal Weight | Maintain | Mar 31, 2025 |
| B of A Securities | Underperform | Underperform | Maintain | Jun 27, 2024 |
| Wedbush | Neutral | Neutral | Maintain | Apr 3, 2024 |
| Evercore ISI Group | In Line | In Line | Maintain | Mar 26, 2024 |
| Credit Suisse | Outperform | Outperform | Maintain | Sep 29, 2022 |
| Cowen & Co. | Outperform | Outperform | Maintain | Sep 29, 2022 |
| Deutsche Bank | Hold | Hold | Maintain | Jun 30, 2022 |
| Wolfe Research | Underperform | Underperform | Maintain | Jul 2, 2021 |
| Goldman Sachs | Sell | Sell | Maintain | Apr 7, 2021 |
| Argus Research | Buy | Buy | Maintain | Apr 7, 2021 |
| Bank of America | Neutral | Underperform | Upgrade | Jan 8, 2019 |
| Stifel Nicolaus | Hold | Hold | Maintain | Oct 3, 2018 |
| Guggenheim | Neutral | Neutral | Maintain | Aug 21, 2018 |
| Argus | Buy | Hold | Upgrade | May 5, 2018 |
| William Blair | Market Perform | Outperform | Downgrade | Jul 21, 2017 |
| Bernstein | Perform | Market Perform | Maintain | Jan 11, 2017 |
| Compass Point | Sell | Sell | Maintain | Apr 15, 2016 |
| Sterne Agee CRT | Neutral | Neutral | Maintain | Dec 17, 2015 |
| First Analysis | Equal Weight | Overweight | Downgrade | Sep 26, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $122.13. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Kevin McVeigh | $115 | $111.96 | -5.8% | Jul 22, 2026 |
| Cantor Fitzgerald | Ramsey El-Assal | $107 | $112.76 | -12.4% | Jul 20, 2026 |
| Morgan Stanley | Analyst unavailable | $109 | $99.81 | -10.8% | Jun 30, 2026 |
| UBS | Analyst unavailable | $98 | $98.84 | -19.8% | Jun 25, 2026 |
| Stifel Nicolaus | Analyst unavailable | $110 | $100.28 | -9.9% | Jun 17, 2026 |
| Morgan Stanley | James Faucette | $107 | $91.68 | -12.4% | Mar 27, 2026 |
| BMO Capital | Daniel Jester | $103 | $92 | -15.7% | Mar 13, 2026 |
| Cantor Fitzgerald | Ramsey El-Assal | $98 | $106.19 | -19.8% | Jan 26, 2026 |
| Morgan Stanley | Analyst unavailable | $123 | $112.28 | +0.7% | Dec 22, 2025 |
| Jefferies | Analyst unavailable | $110 | $112.28 | -9.9% | Dec 19, 2025 |
| Stifel Nicolaus | David Grossman | $126 | $115.22 | +3.2% | Dec 17, 2025 |
| BMO Capital | Analyst unavailable | $121 | $112.45 | -0.9% | Dec 9, 2025 |
| Wells Fargo | Analyst unavailable | $116 | $112.45 | -5.0% | Dec 9, 2025 |
| Jefferies | Analyst unavailable | $118 | $112.06 | -3.4% | Dec 7, 2025 |
| RBC Capital | Ashish Sabadra | $125 | $113.31 | +2.3% | Dec 5, 2025 |
| Wells Fargo | Analyst unavailable | $128 | $127.54 | +4.8% | Oct 21, 2025 |
| Stephens | Charles Nabhan | $135 | $124.37 | +10.5% | Oct 6, 2025 |
| Morgan Stanley | Analyst unavailable | $132 | $126.76 | +8.1% | Oct 1, 2025 |
| BMO Capital | Analyst unavailable | $140 | $126.76 | +14.6% | Oct 1, 2025 |
| Jefferies | Analyst unavailable | $130 | $126.76 | +6.4% | Sep 30, 2025 |
| UBS | Kevin McVeigh | $140 | $131.62 | +14.6% | Sep 16, 2025 |
| Jefferies | Analyst unavailable | $140 | $137.94 | +14.6% | Jun 26, 2025 |
| RBC Capital | Ashish Sabadra | $165 | $150.62 | +35.1% | Jun 24, 2025 |
| Stifel Nicolaus | Analyst unavailable | $156 | $151.83 | +27.7% | Mar 27, 2025 |
| UBS | Kevin McVeigh | $142 | $141.65 | +16.3% | Oct 2, 2024 |
| Barclays | Ramsey El-Assal | $132 | $133.26 | +8.1% | Sep 22, 2024 |
| Argus Research | John Eade | $135 | $118.91 | +10.5% | Jun 28, 2024 |
| Morgan Stanley | James Faucette | $122 | $117.39 | -0.1% | Jun 27, 2024 |
| Robert W. Baird | Mark Marcon | $124 | $117.66 | +1.5% | Jun 27, 2024 |
| Evercore ISI | David Togut | $130 | $117.39 | +6.4% | Jun 26, 2024 |
| Evercore ISI | David Togut | $116 | $120.21 | -5.0% | Apr 2, 2024 |
| Stifel Nicolaus | David Grossman | $130 | $121.5 | +6.4% | Apr 1, 2024 |
| Morgan Stanley | James Faucette | $125 | $112.72 | +2.3% | Sep 27, 2023 |
| RBC Capital | Ashish Sabadra | $130 | $121.37 | +6.4% | Sep 5, 2023 |
| J.P. Morgan | Analyst unavailable | $119 | $116.01 | -2.6% | Dec 23, 2022 |
| Morgan Stanley | Analyst unavailable | $125 | $116.01 | +2.3% | Dec 23, 2022 |
| Barclays | Analyst unavailable | $115 | $116.01 | -5.8% | Dec 23, 2022 |
| Jefferies | Samad Samana | $120 | $112.18 | -1.7% | Dec 22, 2022 |
| Credit Suisse | Kevin Mcveigh | $140 | $113.87 | +14.6% | Jun 30, 2022 |
| Citigroup | Peter Christiansen | $145 | $136.84 | +18.7% | Apr 11, 2022 |
| Bank of America Securities | Jason Kupferberg | $125 | $124.55 | +2.3% | Mar 16, 2022 |
| Cowen & Co. | Bryan Bergin | $145 | $128.28 | +18.7% | Jan 12, 2022 |
| Barclays | Ramsey El Assal | $140 | $133.45 | +14.6% | Dec 23, 2021 |
| Credit Suisse | Kevin Mcveigh | $165 | $133.45 | +35.1% | Dec 23, 2021 |
| Evercore ISI | David Togut | $118 | $133.45 | -3.4% | Dec 23, 2021 |
| MoffettNathanson | Eugene Simuni | $145 | $133.45 | +18.7% | Dec 23, 2021 |
| Stifel Nicolaus | David Grossman | $140 | $132.62 | +14.6% | Dec 22, 2021 |
| BMO Capital | Jeffrey Silber | $118 | $113.86 | -3.4% | Oct 1, 2021 |
| Argus Research | David Coleman | $118 | $105.1 | -3.4% | Jun 28, 2021 |
Track every rating change on PAYX the moment it posts. Free to start.
Start freeMarket reaction
prior-close to event-session closeFollow PAYX with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeTranscript intelligence
What changed
Compared with the prior quarter (FY26 Q3), AI capabilities expanded from 500+ to roughly 600 features with the introduction of the Wise AI platform branding and a payroll-agnostic product strategy powered by a modular tax engine. Paycor integration progressed from bookings recovery to over $100M in delivered cost synergies with cross-sell traction in ASO, PO, and retirement. ASO engagements grew more than 60% year over year. The Perks marketplace surpassed 400,000 employee users and is being expanded to Paycor's 2.5M employees. Management issued initial FY27 guidance targeting 5–6% revenue growth and ~44% adjusted operating margin, representing a moderated but still profitable growth trajectory. The prior quarter's interest-on-funds upward revision was not reiterated as a new change this quarter.
Guidance delta
FY27 outlook targets 5–6% revenue growth (down from FY26's 17%, reflecting the lap of Paycor acquisition revenue), adjusted operating margin of approximately 44%, and EPS growth of 7–9%. Guidance sentiment was maintained and management tone was confident. The prior quarter had seen an upward revision to interest-on-funds guidance; no new upward or downward revision was noted this quarter.
Key takeaways
- FY26 total revenue rose 17% to $6.5B; Q4 EPS of $1.32 beat the $1.31 consensus by 0.76% on revenue of $1.61B, with margins expanding over 70 bps.
- Wise AI platform now powers roughly 600 features and agents drawing on more than 26 trillion data points, with both direct monetization and indirect upsell, pricing, and retention benefits expected.
- Paycor integration delivered over $100M in cost synergies and significant cross-sell momentum in ASO, PO, and retirement solutions.
- New payroll-agnostic product strategy launched via a modular tax engine, broadening the addressable market beyond traditional payroll clients.
- FY27 guidance projects 5–6% revenue growth, approximately 44% adjusted operating margin, and 7–9% EPS growth under a stable macro backdrop.
- The stock initially dipped 1.68% on the report but subsequently rallied 14.9% to $122.13, trading above the analyst consensus target of $108.80.
Management priorities
- Extend Wise AI capabilities across all HCM platforms and commercialize AI-driven features.
- Roll out payroll-agnostic solutions and modular tax engine to non-payroll customers.
- Scale the Perks digital benefits marketplace to Paycor's 2.5M employees and add new benefit offerings.
- Continue Paycor integration with a focus on enterprise cross-sell and broker channel growth.
- Invest in modernized infrastructure to support AI, advisory differentiation, and margin expansion.
Related earnings events
IndustrialsSources
- Earnings call transcript and parsed analysis · 2026-06-24T16:16:13.649578+00:00
- FN2 earnings calendar · 2026-07-30T01:23:13.872335+00:00
- Polygon adjusted daily market bars · 2026-07-30T04:33:09.089914+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-07-30T04:33:09.087203+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated . For educational purposes only; not investment advice.